GHK-Cu increases follicle size and vascularization (VEGF), while TB-500 activates stem cells in the follicle bulge, promoting the anagen (growth) phase
Receptor-Target Mismatch GHK-Cu acts primarily on dermal fibroblasts and basal keratinocytes
Stacking potential: In research discussions, DSIP is sometimes paired with melatonin, magnesium, or GABA-supporting compounds, though stacking increases the risk of excessive sedation
The date of first use should be recorded on the vial, and the medication should be discarded after the specified period following initial puncture, typically 28 days, even if medication remains and the beyond-use date has not been reached
It also dampens local inflammation and supports tendon, ligament, and muscle repair